Published in Klin Med (Mosk) on January 01, 2007
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci U S A (1988) 1.38
Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue Cell (1998) 1.05
Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. Atherosclerosis (1997) 1.04
Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content. Lab Invest (1983) 1.00
Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf) (2015) 0.97
Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. Am J Pathol (1984) 0.94
Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability. Acta Physiol (Oxf) (2015) 0.93
Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem Biophys Res Commun (1989) 0.92
Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells. Thromb Res (1990) 0.92
Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells. Am J Cardiol (1987) 0.92
[Variability of intima-media thickness of the common carotid arteries in Moscow city population without clinical symptoms of atherosclerosis]. Ter Arkh (2011) 0.91
Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta. Atherosclerosis (1997) 0.90
Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab Invest (1983) 0.90
The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol Immunopathol (1992) 0.89
Dissociated cells from different layers of adult human aortic wall. Acta Anat (Basel) (1984) 0.89
Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo. Biochem Biophys Res Commun (1995) 0.89
Direct anti-atherosclerosis-related effects of garlic. Ann Med (1995) 0.88
Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents. Atherosclerosis (1986) 0.86
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res (1992) 0.86
Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. J Lipid Res (1993) 0.86
Trapidil derivatives as potential antiatherosclerotic drugs. Arzneimittelforschung (1987) 0.86
Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Atherosclerosis (1998) 0.85
Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta. Biochem Biophys Res Commun (1982) 0.85
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease. Coron Artery Dis (1993) 0.85
Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima. Exp Mol Pathol (1997) 0.85
Stellate cells in the intima of human aorta. Application of alkaline dissociation method in the analysis of the vessel wall cellular content. Acta Anat (Basel) (1983) 0.85
Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. Am J Pathol (1986) 0.84
[Direct antiatherosclerotic therapy: possible approaches, results of clinical trials]. Patol Fiziol Eksp Ter (2014) 0.84
Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists. Atherosclerosis (1988) 0.84
Atherogenicity of blood serum from patients with coronary heart disease. Lancet (1986) 0.83
Autoantibodies against low-density lipoprotein and atherogenic potential of blood. Ann Med (1993) 0.83
Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein. Atherosclerosis (2001) 0.83
[Study of intima-medial thickness (IMT) of the carotid arteries as an indicator of natural atherosclerosis progress in Moscow population]. Patol Fiziol Eksp Ter (2012) 0.83
Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. Biochem Biophys Res Commun (1990) 0.82
Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential. Biofactors (1997) 0.82
Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture. Atherosclerosis (1990) 0.81
Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis (1993) 0.81
Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells. Exp Mol Pathol (1989) 0.81
Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res (1992) 0.81
[Hypotensive effect of long-acting garlic tablets allicor (a double-blind placebo-controlled trial)]. Ter Arkh (2002) 0.80
Stellate cells of aortic intima: I. Human and rabbit. Tissue Cell (1992) 0.80
Antiatherogenic effect of grape flavonoids in an ex vivo model. Bull Exp Biol Med (2006) 0.80
Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab Invest (1992) 0.80
Contents of mRNAs encoding endosome/lysosome components in normal human aorta and in stage II of atherogenesis: a hidden regulation. Biochemistry (Mosc) (2011) 0.80
[Cholesterol of circulating immune complexes as biomarker of atherosclerosis]. Patol Fiziol Eksp Ter (2012) 0.80
Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions. Exp Mol Pathol (1995) 0.80
[A new method of quantitative estimation of mutant allele in mitochondrial genome]. Patol Fiziol Eksp Ter (2012) 0.80
Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil. Drugs (1992) 0.79
Lipids in cells of atherosclerotic and uninvolved human aorta. III. Lipid distribution in intimal sublayers. Exp Mol Pathol (1991) 0.79
Optimization of the assay for sialic acid determination in low density lipoprotein. J Lipid Res (1998) 0.79
Characteristics of low density lipoprotein isolated from circulating immune complexes. Atherosclerosis (1996) 0.79
Adult human aortic cells in primary culture: heterogeneity in shape. Heart Vessels (1986) 0.79
[Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental investigation)]. Vopr Pitan (1989) 0.79
Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta. Med Biol (1984) 0.79
Primary RIA screening of hybridoma supernatants without use of a negative control. J Immunol Methods (1985) 0.78
Comparative contents of mRNAs of sex steroid receptors and enzymes of their metabolism in arterial walls of men. Biochemistry (Mosc) (2008) 0.78
Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation. Int J Tissue React (1992) 0.78
Intracellular cholesterol accumulation is accompanied by enhanced proliferative activity of human aortic intimal cells. Tissue Cell (1988) 0.78
Artificial HDL as an anti-atherosclerotic drug. Lancet (1984) 0.78
[Effect of the garlic tablets allicor on thrombocyte aggregation in vitro and ex vivo]. Biull Eksp Biol Med (1997) 0.78
Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis. Exp Mol Pathol (1990) 0.78
[Atherogenic cholesterol-containing circulating immune complexes--one of the components of the serum in patients with systemic lupus erythematosus]. Klin Med (Mosk) (2003) 0.78
[Circulating immune complex cholesterol as a biochemical marker of coronary atherosclerosis]. Kardiologiia (1991) 0.78
[Use of allikor for the normalization of fibrinolysis and hemostasis in patients with chronic cerebrovascular diseases]. Klin Med (Mosk) (2001) 0.78
Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta. Atherosclerosis (1984) 0.78
[Allicor efficacy in lowering the risk of ischemic heart disease in primary prophylaxis]. Ter Arkh (2005) 0.77
Sialidases: Therapeutic And Antiatherogenic Potential. Curr Pharm Des (2016) 0.77
Heterogeneity of human aortic cells in regard to RNA content. Blood Vessels (1984) 0.77
Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cells. Exp Mol Pathol (1985) 0.77
Regression of atherosclerotic manifestations in primary culture of human aortic cells: effects of prostaglandins. Biomed Biochim Acta (1984) 0.77
Gap junctional communication in primary culture of cells derived from human aortic intima. Tissue Cell (1995) 0.77
Diabetes mellitus and atherosclerosis. N Engl J Med (1987) 0.77
Stellate cells of aortic intima: II. Arborization of intimal cells in culture. Tissue Cell (1992) 0.77
Monoclonal antibody reveals heterogeneity in human aortic intima: detection of a ganglioside antigen associated with a subpopulation of intimal cells. Am J Pathol (1986) 0.77
Lipids in cells of atherosclerotic and uninvolved human aorta. II. Lipid metabolism in primary culture. Exp Mol Pathol (1985) 0.77
Evaluation of cell proliferation in human atherosclerotic lesions. Methods Mol Med (2001) 0.77
Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay. Clin Chem (1995) 0.76
Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro. Arch Physiol Biochem (2008) 0.76
The gangliosides of adult human aorta: intima, media and plaque. Eur J Biochem (1987) 0.76